EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Interferon-stimulated gene IFI27 as a multifaceted candidate target in precision medicine

Maryam Shojaei, Anthony S McLean

Trends in Immunology · 2025

DOI: 10.1016/j.it.2025.01.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2025. Verfasst von Maryam Shojaei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia; Departme…. Hauptthemen laut MEDLINE: Precision Medicine, Interferons, Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IFI27, an interferon (IFN)-stimulated gene, is emerging as a crucial player in immune responses across various species, with significant implications for precision medicine. Commonly found among the most upregulated genes in infections, cancers, as well as inflammatory and autoimmune disorders, IFI27 is ready to be trialed in clinical practice for certain indications, and holds promise as an immunomodulatory target. We hypothesize that IFI27 plays a dual role, typically supporting immune defense but sometimes contributing to disease progression, which might render it a putative biomarker for diagnosis, prognosis, and treatment response. We advocate for focused research on IFI27 to unlock its potential in precision medicine and to contribute to a unifying framework of its mechanisms in the immune response. Our viewpoint is supported by numerous studies highlighting IFI27's involvement across various conditions and the possibilities for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineInterferonsNeoplasmsHumansAnimalsBiomarkersAutoimmune DiseasesImmunity, InnateMembrane Proteins

Stichwörter der Autor:innen

IFI27disease gene biomarkerhost immune responseimmunomodulationinterferon-stimulated geneneoplasiaprecision medicinesepsis

Substanzen

IFI27 protein, humanInterferonsBiomarkersMembrane Proteins

Autor:innen und Institutionen

  • Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia; Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW, Austra…
  • Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia; Faculty of Medicine and Health, Sydney Medical School Nepean, Nepean Hospital,…

Zitieren

APA

Shojaei, M., & McLean, A. S. (2025). Interferon-stimulated gene IFI27 as a multifaceted candidate target in precision medicine. Trends in Immunology. https://doi.org/10.1016/j.it.2025.01.008

Vancouver

Shojaei M, McLean AS. Interferon-stimulated gene IFI27 as a multifaceted candidate target in precision medicine. Trends in Immunology. 2025. doi:10.1016/j.it.2025.01.008

BibTeX
@article{Shojaei2025,
  author = {Shojaei, Maryam and McLean, Anthony S},
  title = {Interferon-stimulated gene IFI27 as a multifaceted candidate target in precision medicine},
  journal = {Trends in Immunology},
  year = {2025},
  doi = {10.1016/j.it.2025.01.008}
}
Kostenlos starten →